Genetic Testing
ATAC Sequencing and Analysis
ATAC-seq for research profiling of chromatin accessibility in an agreed sample; it is not a personal health diagnostic.
About this service
ATAC-seq uses transposase-accessible chromatin followed by sequencing to profile open chromatin regions. The profile depends on cell type, sample quality, preparation and analysis; it does not directly measure gene expression, diagnose disease or identify a treatment for an individual.
Service highlights
- Research assay for chromatin-accessibility profiles.
- Requires a defined cell/sample and suitable preparation.
- Accessibility data are not a clinical diagnosis or direct expression result.
Who may consider it
- Epigenomics and gene-regulation researchers.
- Laboratories planning a defined ATAC-seq experiment.
What to expect
Confirm current project availability and quote. Ask whether the input is cells/nuclei, a prepared library or sequencing data and whether sample preparation, transposition, library preparation, sequencing, analysis and QC are included. Agree handling, outputs and turnaround; no SOP is supplied.
Scope and limitations
This listing describes a research ATAC-seq workflow. Accessibility patterns are context-dependent and do not establish disease mechanism, diagnosis, individual risk or therapeutic target without separate research and validation.
Frequently asked questions
What does ATAC-seq measure?
It profiles genomic regions accessible to transposase in a defined research sample.
What input and deliverables are included?
Confirm cell/nuclei requirements and whether preparation, sequencing, analysis, QC and particular files are included.
Is this a personal diagnostic or available now?
No clinical diagnostic use is established. Confirm current project availability and quote.